Seeking Alpha

ruyi22

ruyi22
Send Message
View as an RSS Feed
View ruyi22's Comments BY TICKER:
Latest  |  Highest rated
  • Poniard Pharmaceuticals: Oversold, Undervalued, Poised for Short Squeeze [View article]
    Thanks
    Jun 23, 2010. 03:26 PM | Likes Like |Link to Comment
  • How to Spot a Short Biotech Opportunity, Part III [View instapost]
    Brilliant Article,

    Firstly the poniard trial was based on 401 patients, well you might say a difference of 2,thought it would be better to emphasis as it's just over 400.

    Secondly as an ordinary citiizen with a donkeys expertise in your field I would rather use a drug with lower toxic side effects.

    Well Poniard are in the process of pursuing FDA approval, we will wait and see.
    Jun 22, 2010. 03:39 AM | Likes Like |Link to Comment
  • Poniard Pharmaceuticals: Oversold, Undervalued, Poised for Short Squeeze [View article]
    Hi Joeseph what are your current thoughts on Poniard Pharma?
    Jun 21, 2010. 04:20 PM | Likes Like |Link to Comment
COMMENTS STATS
3 Comments
0 Likes